Abstract:Purpose: The molecular links between metabolism and inflammation that drive different inflammatory phenotypes in asthma are poorly understood. We aimed to identify the metabolic signatures and underlying molecular pathways of different inflammatory asthma phenotypes. Methods: In the discovery set (n = 119), untargeted ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) was applied to characterize the induced sputum metabolic profiles of asthmatic patients with different inflammatory phenotypes using orthogonal partial least-squares discriminant analysis (OPLS-DA), and pathway topology enrichment analysis. In the validation set (n = 114), differential metabolites were selected to perform targeted quantification. Correlations between targeted metabolites and clinical indices in asthmatic patients were analyzed. Logistic and negative binomial regression models were established to assess the association between metabolites and severe asthma exacerbations. Results: Seventy-seven differential metabolites were identified in the discovery set. Pathway topology analysis uncovered that histidine metabolism, glycerophospholipid metabolism, nicotinate and nicotinamide metabolism, linoleic acid metabolism as well as phenylalanine, tyrosine and tryptophan biosynthesis were involved in the pathogenesis of different asthma phenotypes. In the validation set, 24 targeted quantification metabolites were significantly expressed between asthma inflammatory phenotypes. Finally, adenosine 5 '-monophosphate (adjusted relative risk [adj RR] = 1.000; 95% confidence interval [CI] = 1.000-1.000; P = 0.050), allantoin (adj RR = 1.000; 95% CI = 1.000-1.000; P = 0.043) and nicotinamide (adj RR = 1.001; 95% CI = 1.000-1.002; P = 0.021) were demonstrated to predict severe asthma exacerbation rates. Conclusions: Different inflammatory asthma phenotypes have specific metabolic profiles in induced sputum. The potential metabolic signatures may identify therapeutic targets in different inflammatory asthma phenotypes.

Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.

Metabolomic Profiling Differences among Asthma, COPD and Healthy Controls: a LC-MS-based Metabolomics Analysis

Urinary Metabolomic Profiling Reveals Biological Pathways and Predictive Signatures Associated with Childhood Asthma

Metabolic Alterations in the Sera of Chinese Patients with Mild Persistent Asthma: a GC-MS-based Metabolomics Analysis

Sputum Metabolomic Profiling Reveals Metabolic Pathways and Signatures Associated with Inflammatory Phenotypes in Patients with Asthma

Serum Metabolomics Reveals Metabolomic Profile and Potential Biomarkers in Asthma

Metabolomics analysis identifies different metabotypes of asthma severity

Assessment of Serum Metabolism and Eicosanoid Profiling in Pediatric Asthma and Bronchiolitis via Liquid Chromatography‐Mass Spectrometry

Metabolomic Analysis of Serum Glycerophospholipid Levels in Eosinophilic and Neutrophilic Asthma.

Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma.

Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study

[Metabolomics Analysis Identifies Serum Glycerophospholipid Expression: a Comparison Between Men and Women with Asthma].

Metabolomic analysis of lung cancer patients with chronic obstructive pulmonary disease using gas chromatography-mass spectrometry

Metabolomic differences of exhaled breath condensate among children with and without asthma

A Comparison of Serum and Sputum Inflammatory Mediator Profiles in Patients with Asthma and COPD.

Research Progress of Metabolomics in Asthma

Detection of the Disorders of Glycerophospholipids and Amino Acids Metabolism in Lung Tissue From Male COPD Patients

Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.

Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization

Urinary metabolomic profiles uncover metabolic pathways in children with asthma

Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort